agilon health, inc.

NYSE:AGL

3.48 (USD) • At close February 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -126.846-30.6823.217-167.088-31.483-16.79515.959-56.549-30.739-20.7311.155-56.737-35.958-298.941-15.151-24.215-11.827-7.911-16.099-149.311
Depreciation & Amortization 6.2185.9075.8444.7355.315.5154.1893.9073.453.0423.3733.6383.9373.6143.4813.7533.5013.4823.363-25.825
Deferred Income Tax 00.41700.2671.211.073066.728000-3.2310.452-2.1281.186-23.1770.347-0.3800
Stock Based Compensation 13.25918.20716.90915.51520.73619.57213.6729.9517.9076.5533.974.41411.96274.5481.4721.771.6162.2311.0710.919
Change In Working Capital 67.312-3.977-63.33595.6236.267-20.487-91.470.18216.951-46.314-30.254-7.4022.588-16.629-33.58225.7352.512-6.476-15.29925.167
Accounts Receivables 0000000-204.167000-149.041000-59.3810000
Change In Inventory 0000000204.167000000000000
Change In Accounts Payables 00032.11100065.73600019.3600000000
Other Working Capital 67.312-3.977-63.33595.6236.267-20.487-91.47-65.55416.951-46.314-30.254-26.7622.588-16.629-33.58225.7352.512-6.476-15.29925.167
Other Non Cash Items 32.35421.84918.186-10.218-15.058-10.082-3.161-74.1780.764-2.813-1.47710.421-2.1220.2451.7662.795-0.516-0.3170.837120.913
Operating Cash Flow -7.703-18.717-47.776-61.166-13.018-21.204-60.811-49.9592.647-60.263-23.233-48.897-19.143-39.291-40.828-13.339-4.367-9.371-26.127-28.137
Investing Activities:
Investments In Property Plant And Equipment 14.359-9.767-14.577-15.382-5.785-5.931-3.717-8.309-3.68-15.623-5.049-3.468-5.294-0.5-4.164-0.56-0.543-0.869-0.378-0.694
Acquisitions Net 0001.42-0.112-1.837-44.367-0.500.50.51.301.062-3.70624.381.825000
Purchases Of Investments 0-12.0060-7.637-41.452-35.599-29.969-35.082-138.106-285.077-0.683000000000
Sales Maturities Of Investments 51.08141.22474.52330.14636.62568.72928.5437.42110.8483.5960.683000000000
Other Investing Activites -18.877-1.234-8.508-10.75-0.31-5.33-1.301-1.5-4.279-0.007-4.32-0.435-6.271-67.826-1.204-0.546-0.139-1.8010.697-0.314
Investing Cash Flow 46.56318.21751.438-2.203-11.03420.032-50.814-7.97-130.938-296.611-8.869-2.603-11.565-67.264-9.07423.2741.143-2.670.319-1.008
Financing Activities:
Debt Repayment -1.25-1.25-1.250-1.25-1.25-1.25-1.25-1.25-1.25-1.25-1.2520.001-49.99931.3512.281-0.761-0.76-0.76-0.76
Common Stock Issued -0.156-0.4641.8090.4052.66-0.7879.5892.3810.3615.55914.75616.481.0551,170.9420.16500.8634.59928.1280
Common Stock Repurchased 0000000000000000-6.742000
Dividends Paid 00000000000000000000
Other Financing Activities 000-1.25000000011.669-0.16-8.164-1.053-3.0410.9980.3150105.024
Financing Cash Flow -1.406-1.7140.559-0.8451.41-202.0378.3391.139.1114.30913.50610.4170.8961,112.77930.298-0.76-6.1414.15427.368104.264
Other Information:
Effect Of Forex Changes On Cash 000-145.59218.415212.57400000-9.36500000000
Net Change In Cash 37.454-2.2144.221-64.214-22.642-203.209-103.286-56.799-119.18-352.565-18.596-41.083-29.8121,006.224-19.6049.175-9.365-7.8871.5675.119
Cash At End Of Period 153.79116.336118.55114.329178.543201.185404.394507.68564.479683.6591,036.2241,054.821,095.9031,125.715119.491139.095129.92139.285147.17275.119